Previous 10 | Next 10 |
111 (YI -2.9%) has announced a strategic cooperation agreement with Suzhou Zelgen Biopharmaceuticals, an innovative drug R&D and production company. The agreement will allow 111 and Zelgen to build an innovative out-of-hospital, virtual management platform for liver cancer patients t...
ECMOHO (NASDAQ:MOHO) -33% after pricing $9M ADS offering Ever-Glory International (NASDAQ:EVK) -20%. Newtek Business Services (NASDAQ:NEWT) -18% agrees to buy National Bank of New York City in plan to be bank holding co. The Clorox (NYSE:CLX) -11% on FQ4 earnings...
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China PR Newswire SHANGHAI , Aug. 3, 2021 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-ena...
Palm Beach, FL – June 17, 2021 – In the past few years, in many countries, the adoption of electronic medical records technology is upsurging at a fast pace and is creating a new and growing global market… The Electronic Health Records Market (EHR). It is occurring beca...
Image source: The Motley Fool. 111 Inc (NASDAQ: YI) Q1 2021 Earnings Call May 19, 2021 , 7:30 a.m. ET Monica Mu -- Investor Relations Director Continue reading For further details see: 111 Inc (YI) Q1 2021 Earnings Call Transcript
The following slide deck was published by 111, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: 111, Inc. 2021 Q1 - Results - Earnings Call Presentation
111, Inc. (YI) Q1 2021 Earnings Conference Call May 19, 2021, 07:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, Major Subsidiary Harvey Wang - Co-COO Barry Zhu - Co-COO Tiffany Jugal - SVP, IR and Business ...
111 ([[YI]] -15.2%) reports Q1 revenue of $396M, representing an increase of 64.7% Y/Y; revenue growth was 89% excluding pandemic-related items.Operating expense increased 43.6% Y/Y.Loss from operations was RMB173.3M (or $26.4M), compared to RMB113.7M in the same quar...
Gainers: MoSys (MOSY) +32%.Lianluo Smart (LLIT) +30%.Advaxis (ADXS) +27%.Reata Pharmaceuticals (RETA) +22%.LifeMD (LFMD) +18%.Taitron Components (TAIT) +17%.FreightCar America (RAIL) +14%.Transcat (TRNS) +14%.PureCycle Technologies (PCT) +14%.Aehr Test Systems (AEHR) +12%.Losers:...
Gainers: Reata Pharmaceuticals (RETA) +20%, LifeMD (LFMD) +13%, Eloxx Pharmaceuticals (ELOX) +10%, Cerecor (CERC) +10%, Biofrontera (BFRA) +7%.Losers: Onconova Therapeutics (ONTX) -23%, Iovance Biotherapeutics (IOVA) -18%,&...
News, Short Squeeze, Breakout and More Instantly...
111 Announces Appointment of New Auditor PR Newswire SHANGHAI , July 19, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digi...
111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024 PR Newswire SHANGHAI July 17, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the ...
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility PR Newswire SHANGHAI , June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare plat...